Introduction: Elevated intraocular pressure (IOP) remains the most important modifiable risk factor in the progression of open-angle glaucoma (OAG) and ocular hypertension (OHT) (1). Despite multiple therapeutic options, limitations persist with existing agents such as β-blockers (e.g., timolol), including systemic side effects, variable efficacy a

Abstract Neovascular glaucoma (NVG) is a vision-threatening secondary glaucoma caused by anterior segment neovascularization due to retinal ischemia. We report a case of NVG secondary to ischemic central retinal vein occlusion (CRVO), emphasizing early diagnosis and multimodal management. Introduction Neovascular glaucoma is commonly associated wit

Introduction Neurotrophic Keratopathy (NK) is a progressive corneal disorder caused by impaired trigeminal innervation, leading to reduced corneal sensitivity and compromised epithelial healing (1). In Stage 1 NK, patients present with superficial punctate keratopathy and early epithelial irregularities that may progress if untreated (1). Cenegermi

Introduction Immunoglobulin G4-related disease (IgG4-RD) is a systemic, immune-mediated fibroinflammatory condition characterized by tumefactive lesions, a dense lymphoplasmacytic infiltrate rich in IgG4-positive plasma cells, and storiform fibrosis (1). While it can affect nearly any organ system, the ocular adnexa are involved in up to 25–40% of

Tolebrutinib introduces a promising shift in the management of non-relapsing secondary progressive multiple sclerosis, a disease of the brain and spinal cord (1). By addressing smoldering neuroinflammation, it opens the door to earlier and more proactive intervention in disability progression.

PRESENTATION 30-year-old male Medical history of fever for about 2 weeks. After the flu subsided, the patient felt pain in the eyes during eye movement. He visited an ophthalmologist in another clinic for evaluation, and eye drops were given. On day 5, he developed blurry and decreased vision and visited Aster for re-evaluation. He was seen by an O

INTRODUCTION The prevalence of myopia has increased markedly over recent decades and is projected to continue rising worldwide (1). In 2020, approximately 30% of the global population was estimated to be myopic, and projections indicate that this proportion may reach 50% by 2050 (2). Within this expanding burden, the prevalence of high myopia is al

Introduction: Neurotrophic keratopathy (NK) is a rare degenerative corneal disease caused by damage to the trigeminal nerve, leading to reduced or absent corneal sensation (1). This results in epithelial breakdown, ulceration, opacification, and possible perforation, often causing visual disability (1). Read the article to discover key mechanisms b

Introduction: Neurotrophic keratopathy is a degenerative corneal disease caused by impairment of the trigeminal nerve, leading to reduced corneal sensitivity and disruption of epithelial maintenance and healing (1). This condition can progress to persistent epithelial defects, stromal ulceration, and even perforation, posing a significant threat to